PW01 - Vincent T. Andriole ID Board Review Course ($)

Tuesday, October 18, 2022

8:00 AM – 5:30 PM US ET

Location: 202 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Andrea Zimmer, MD

Assistant Professor
Internal Medicine
University of
Omaha, Nebraska, United States

Disclosure(s): No financial relationships to disclose
Stuart Cohen, MD

Medical Director of Hospital Epidemiology; Division Chief, Infectious Diseases
University of California, Davis
Sacramento, CA, United States

Disclosure(s): No financial relationships to disclose

Faculty(s)

Khalil Ghanem, MD, PhD

Professor
Division of Infectious Diseases, Department of Medicine
Johns Hopkins University
Baltimore, Maryland, United States

Disclosure(s): No financial relationships to disclose

Slides
Roy Gulick, MD, MPH

Professor of Medicine Chief, Division of Infectious Diseases
Weill Cornell Medicine
New York, NY, United States

Disclosure(s): No financial relationships to disclose

Slides
Philip Budge, MD, PhD

Associate Professor
Washington University St. Louis
St. Louis, MO, United States

Disclosure(s): No financial relationships to disclose

Slides
Cody Chastain, MD, FACP, FIDSA (he/him/his)

Assistant Professor of Medicine
Department of Medicine, Division of Infectious Diseases
Vanderbilt University Medical Center
Nashville, TN, United States

Disclosure(s): No financial relationships to disclose

Slides
Lisa Armitige, MD, PHD

Assistant Medical Director
Heartland National TB Center
San Antonio, TX, United States

Disclosure(s): No financial relationships to disclose

Slides
Thomas Patterson, MD

Professor and Chief, Infectious Diseases
University of Texas Health San Antonio
San Antonio, TX, United States

Disclosure(s): Basilea Pharmaceutica: Advisor/Consultant (Ongoing); Cidara Therapeutics Inc.: Grant/Research Support (Terminated); F2G Limited: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Gilead Biosciences: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Merck & Co. Inc: Advisor/Consultant (Ongoing); Pfizer, Inc.: Advisor/Consultant (Ongoing); Scynexis Inc.: Advisor/Consultant (Ongoing); Sfunga Therapeutics: Advisor/Consultant (Ongoing)

Slides
Rachael Lee, MD, MSPH

Associate Professor
Medicine
University of Alabama at Birmingham
Birmingham, AL, United States

Disclosure(s): No financial relationships to disclose

Slides
Gerome Escota, MD

Infectious Disease Physician
Park Nicollet Specialty Center

Disclosure(s): No financial relationships to disclose

Slides
Catherine O'Neal, MD

Associate Professor of Clinical Medicine, Infectious Diseases
Infectious Diseases
Louisiana State University Health Baton Rouge
Baton Rouge, LA, United States

Disclosure(s): No financial relationships to disclose

Slides
Barbara Taylor, MD, MS

Professor
University of Texas Health Science Center San Antonio
San Antonio, TX, United States

Disclosure(s): Gilead Sciences Inc.: Grant/Research Support (Ongoing)

Slides
Karen Bloch, MD, MPH

Professor
Vanderbilt University Medical Center
Nashville, TN, United States

Disclosure(s): No financial relationships to disclose

Slides
Jessica Lum, MD

Dr
Cleveland Clinic Foundation
Cleveland, OH, United States

Disclosure(s): No financial relationships to disclose

Slides

Disclosure(s):

Andrea J. Zimmer, MD: No financial relationships to disclose

Stuart H. Cohen, MD: No financial relationships to disclose

Khalil G. Ghanem, MD, PhD: No financial relationships to disclose

Roy Gulick, MD, MPH: No financial relationships to disclose

Philip Budge, MD, PhD: No financial relationships to disclose

Cody A. Chastain, MD, FACP, FIDSA: No financial relationships to disclose

Lisa Y. Armitige, MD, PHD: No financial relationships to disclose

Thomas F. Patterson, MD: Basilea Pharmaceutica: Advisor/Consultant (Ongoing); Cidara Therapeutics Inc.: Grant/Research Support (Terminated); F2G Limited: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Gilead Biosciences: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Merck & Co. Inc: Advisor/Consultant (Ongoing); Pfizer, Inc.: Advisor/Consultant (Ongoing); Scynexis Inc.: Advisor/Consultant (Ongoing); Sfunga Therapeutics: Advisor/Consultant (Ongoing)

Rachael A. Lee, MD, MSPH: No financial relationships to disclose

Gerome Escota, MD: No financial relationships to disclose

Catherine S. O'Neal, MD: No financial relationships to disclose

Barbara S. Taylor, MD, MS: Gilead Sciences Inc.: Grant/Research Support (Ongoing)

Karen C. Bloch, MD, MPH: No financial relationships to disclose

Jessica Lum, MD: No financial relationships to disclose

CME Credits: Maximum of 7.5 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 7.5 hours of MOC Credit
CNE Credits: Maximum of 7.5 hours of ANCC Credit
ACPE Credits: ACPE 7.5 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss and apply updated information on diagnosis and treatment of sexually transmitted infections;
assess and apply current trends in diagnosis and treatment of tuberculosis and other mycobacteria;
discuss the diagnosis and treatment of fungal infections;
describe common parasitic disease infections, including their diagnosis and treatment;
recognize and apply in diagnostic and therapeutic ways the epidemiologic, tempo- and sign/symptom features of important bacterial infections;
assess and apply components of effective infection control/prevention programs;
discuss the most common noninfectious causes of elevated temperature;
discuss and apply updated information ID therapeutics;
assess and apply current trends in the diagnosis and treatment of transplant-associated infections;
analyze and apply current trends in HIV care

Presentations:

8:15 AM – 8:50 AM US ET

Sexually Transmitted Diseases
Workshop Speaker: Khalil G. Ghanem, MD, PhD – Johns Hopkins University
8:50 AM – 9:25 AM US ET

Mycobacteria Including TB
Workshop Speaker: Lisa Y. Armitige, MD, PHD – Heartland National TB Center
9:25 AM – 10:00 AM US ET

Fungal Infections
Workshop Speaker: Thomas F. Patterson, MD – University of Texas Health San Antonio
10:15 AM – 10:50 AM US ET

ID Therapeutics: A Broad Overview
Workshop Speaker: Rachael A. Lee, MD, MSPH – University of Alabama at Birmingham
10:50 AM – 11:25 AM US ET

Bacterial Syndrome Pearls
Workshop Speaker: Gerome Escota, MD – Park Nicollet Specialty Center
11:25 AM – 12:00 PM US ET

Infection Control and Prevention
Workshop Speaker: Catherine S. O'Neal, MD – Louisiana State University Health Baton Rouge
1:30 PM – 2:05 PM US ET

Noninfectious Causes of Elevated Temperature
Workshop Speaker: Barbara S. Taylor, MD, MS – University of Texas Health Science Center San Antonio
2:05 PM – 2:40 PM US ET

Nervous System Infections and Mimics
Workshop Speaker: Karen C. Bloch, MD, MPH – Vanderbilt University Medical Center
2:40 PM – 3:15 PM US ET

Transplant Infections
Workshop Speaker: Jessica Lum, MD – Cleveland Clinic Foundation
3:30 PM – 4:05 PM US ET

HIV
Workshop Speaker: Roy Gulick, MD, MPH – Weill Cornell Medicine
4:05 PM – 4:40 PM US ET

Parasitic Diseases
Workshop Speaker: Philip Budge, MD, PhD – Washington University St. Louis
4:40 PM – 5:15 PM US ET

Viral Diseases
Workshop Speaker: Cody A. Chastain, MD, FACP, FIDSA (he/him/his) – Vanderbilt University Medical Center